|
|
| Technical Excellence In ADC Manufacturing | On October 24, join industry experts for an exclusive series of cutting-edge presentations on demonstrating technical excellence in process development and manufacturing for ADCs and bioconjugates. Register to gain access to expert knowledge that will drive innovation and accelerate your ADC development and manufacturing program. Gain valuable insights on successfully scaling up from PAD to manufacturing, leveraging an integrated linker-payload supply chain, and implementing Process Analytical Technology (PAT). Register here. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | How could I not ask him for an opinion regarding our vigorously pursued editorials on the WuXi Apptec–BIOSECURE Act. After all, Reza Oliyai has outsourced a myriad of development and manufacturing services to hundreds of CDMOs around the world. He did so at Gilead for decades, and since as the CEO of his eponymous consulting company. His response did not disappoint. |
|
|
August 2024 — CDMO Opportunities And Threats Report | By Outsourced Pharma | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. |
|
|
No Strategic Outsourcing Without An Internal Strategy | By Outsourced Pharma Live | Antiksha Joshi, Urmi Quality Management Consulting, and Reza Oliyai, Oliyai Consulting, stress the need to establish a coherent, internal outsourcing strategy at biotechs before looking to form strategic partnerships at CDMOs, and provide some examples. |
|
|
|
|
|
The Art And Science Of Pre-Picking Tablet Designs | Article | Natoli Engineering Company, Inc. | Picking and sticking are the most common tablet defects that can reduce your product quality and performance. This makes perfecting the right pre-picking strategy essential to improving your processes. |
|
|
|
|
|
Method Optimization | Cambrex | We offer a comprehensive method optimization service to take early stage development methods with poor stability indication, excessive run time lengths, or legacy column chemistries and modify them. |
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
